Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation

Congenit Anom (Kyoto). 2005 Jun;45(2):59-61. doi: 10.1111/j.1741-4520.2005.00064.x.

Abstract

Hereditary lymphedema type I (Milroy disease) is a rare autosomal dominant disease resulting from mutations of FLT4 encoding the vascular endothelial growth factor receptor-3. Patients develop edema of the legs and feet, resulting in chronic swelling of the lower extremities from the neonatal period. Here we report a Japanese family with 10 affected members of five generations of hereditary lymphedema type I. We identified a previously reported missense mutation of G857R in one allele of FLT4 from three affected individuals of three generations, the mother of whom presented only hemi-lymphedema of the left foot. Thus, the clinical features of hereditary lymphedema type I caused by a FLT4 mutation are heterogeneous and it would be appropriate to consider FLT4 mutations even in a patient with hemi-lymphedema of the foot.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Family Health
  • Female
  • Foot Diseases / congenital
  • Foot Diseases / genetics
  • Foot Diseases / pathology
  • Genotype
  • Humans
  • Lymphedema / congenital*
  • Lymphedema / genetics*
  • Lymphedema / pathology
  • Male
  • Mutation, Missense
  • Pedigree
  • Vascular Endothelial Growth Factor Receptor-3 / genetics*

Substances

  • Vascular Endothelial Growth Factor Receptor-3